In vivo protective effects of UCMA against cartilage degeneration in monosodium iodoacetate-induced osteoarthritis model.
In conclusion, UCMA exhibited a therapeutic potential in the treatment of OA. This protective effect of UCMA is possibly achieved by reducing the aggrecanase activity and the production of inflammatory cytokines.
PMID: 32640182 [PubMed - as supplied by publisher]
Source: Canadian Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Authors: Okuyan HM, Terzi MY, Karaboga İ, DoĞan S, Kalaci A Tags: Can J Physiol Pharmacol Source Type: research
More News: Antidoxidants | Canada Health | Drugs & Pharmacology | Osteoarthritis | Physiology | Vitamin K | Vitamins